ConductScience.org, home

Paper23318809

Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.

Rodgers W and 2 others. Antimicrob Agents Chemother, 2013. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. Papers, record 23318809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23318809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.43
iCite
Revised in PubMed
2021-10-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rodgers WWard
2Frazier ADAshley D
3Champney WSW Scott

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Haemophilus influenzaeMajor topic
MacrolidesMajor topic
RibosomesMajor topic
Staphylococcus aureusMajor topic
Streptococcus pneumoniaeMajor topic
TriazolesMajor topic
Anti-Infective Agents
Inhibitory Concentration 50
Protein Biosynthesis

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111270656Structure-activity relationships for six ketolide antibiotics.Curr Microbiol2001https://conductscience.org/library/papers/11270656PubMed
212177734The ketolide antibiotic ABT-773 is a specific inhibitor of translation and 50S ribosomal subunit formation in Streptococcus pneumoniae cells.Curr Microbiol2002https://conductscience.org/library/papers/12177734PubMed
317562806Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17562806PubMed
420176910CEM-101 activity against Gram-positive organisms.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20176910PubMed
520831882The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009).J Infect2010https://conductscience.org/library/papers/20831882PubMed
612520364Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.Curr Microbiol2003https://conductscience.org/library/papers/12520364PubMed
719884376In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/19884376PubMed
817168803The other target for ribosomal antibiotics: inhibition of bacterial ribosomal subunit formation.Infect Disord Drug Targets2006https://conductscience.org/library/papers/17168803PubMed
916096836Accumulation and turnover of 23S ribosomal RNA in azithromycin-inhibited ribonuclease mutant strains of Escherichia coli.Arch Microbiol2005https://conductscience.org/library/papers/16096836PubMed
1019564365
Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.
Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19564365PubMed
1110940010RNase III processing of intervening sequences found in helix 9 of 23S rRNA in the alpha subclass of Proteobacteria.J Bacteriol2000https://conductscience.org/library/papers/10940010PubMed
1210216268Fragmentation heterogeneity of 23S ribosomal RNA in Haemophilus species.Gene1999https://conductscience.org/library/papers/10216268PubMed
1322191530Antibiotics in development targeting protein synthesis.Ann N Y Acad Sci2011https://conductscience.org/library/papers/22191530PubMed
1421862408Resistance drives antibacterial drug development.Curr Opin Pharmacol2011https://conductscience.org/library/papers/21862408PubMed
1511544246Intervening sequences in rrl genes and fragmentation of 23S rRNA in genera of the family Enterobacteriaceae.J Bacteriol2001https://conductscience.org/library/papers/11544246PubMed
1610648538Fragmentation of 23S rRNA in strains of Proteus and Providencia results from intervening sequences in the rrn (rRNA) genes.J Bacteriol2000https://conductscience.org/library/papers/10648538PubMed
1720211548Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.Int J Antimicrob Agents2010https://conductscience.org/library/papers/20211548PubMed
1820022192CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.Diagn Microbiol Infect Dis2010https://conductscience.org/library/papers/20022192PubMed
1912232662Telithromycin inhibition of protein synthesis and 50S ribosomal subunit formation in Streptococcus pneumoniae cells.Curr Microbiol2002https://conductscience.org/library/papers/12232662PubMed
2020855725Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20855725PubMed

See all 25 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
40212381Exploring the repurposed role of solithromycin as an antivirulence agent against Staphylococcus aureus and its resistant variants.Front Microbiol2025https://conductscience.org/library/papers/40212381PubMed
38554170Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement.Mol Divers2024https://conductscience.org/library/papers/38554170PubMed
34546703Development of Genetically Encoded Biosensors for Reporting the Methyltransferase-Dependent Biosynthesis of Semisynthetic Macrolide Antibiotics.ACS Synth Biol2021https://conductscience.org/library/papers/34546703PubMed
32119845The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae.Transl Res2020https://conductscience.org/library/papers/32119845PubMed
31942624Antibiotics targeting bacterial ribosomal subunit biogenesis.J Antimicrob Chemother2020https://conductscience.org/library/papers/31942624PubMed
29891609Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29891609PubMed
29678883Ribosome maturation by the endoribonuclease YbeY stabilizes a type 3 secretion system transcript required for virulence of enterohemorrhagic Escherichia coli.J Biol Chem2018https://conductscience.org/library/papers/29678883PubMed
29263651Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.Drug Des Devel Ther2017https://conductscience.org/library/papers/29263651PubMed
29068158Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid.CPT Pharmacometrics Syst Pharmacol2017https://conductscience.org/library/papers/29068158PubMed
28971877In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28971877PubMed
27974410The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.Clin Microbiol Rev2017https://conductscience.org/library/papers/27974410PubMed
27909995Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.Drugs2016https://conductscience.org/library/papers/27909995PubMed
27401563Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27401563PubMed
27353164Antibiotics in the clinical pipeline at the end of 2015.J Antibiot (Tokyo)2017https://conductscience.org/library/papers/27353164PubMed
27066004A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy.Front Immunol2016https://conductscience.org/library/papers/27066004PubMed
27044551Results from the Solithromycin International Surveillance Program (2014).Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27044551PubMed
24236721Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Curr Top Med Chem2014https://conductscience.org/library/papers/24236721PubMed
24189250Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24189250PubMed
24092856Investigational antimicrobial agents of 2013.Clin Microbiol Rev2013https://conductscience.org/library/papers/24092856PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23318809

GET https://conductscience.org/api/papers/v1/23318809/references?page=2